Investing.com - 默沙东集团(Merck) (NYSE:MRK)周二公布了第二季度财报，每股收益超出分析师预期，而收入略低于预期，同时该公司缩小了全年展望范围。 该公司股价在盘前交易中下跌近1%。

The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster ...

Drugmaker Merck & Co on Tuesday announced job and cost cuts it said will save $3 billion a year as it posted lower ...

Conflicts raise serious questions about whether health policy under Kennedy will be guided by science or steered by ...

U.S. Health Secretary Robert F. Kennedy Jr. announced plans to reform the National Vaccine Injury Compensation Program (VICP) ...

Merck is heading into its second-quarter earnings report on Tuesday with important pillars of its business increasingly under ...

US Health and Human Services Secretary Robert F. Kennedy Jr. said Monday that he is working with the Justice Department to ...

U.S. Health Secretary Robert F. Kennedy Jr. said on Monday that he will work to "fix" the program that compensates victims of ...

Merck has had a successful track record of beating estimates, having surpassed EPS expectations 88% of the time and beating ...

Merck & Co., Inc. (NYSE:MRK) is one of the top low volatility healthcare stocks to buy now. Analyst Daina Graybosch of ...

Science does not support aluminum as a culprit of autism. Yet RFK Jr. and his associates continue to find ways to support the ...

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...